IP Library Granted Patent US 8,440,408
Granted Patent B2
US 8,440,408 · App. 12/965,111 · Granted May 14, 2013

Animal protein-free media for cultivation of cells

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,440,408
App. No.
12/965,111
Granted
May 14, 2013
Kind
B2
Abstract

The present invention relates to animal protein-free cell culture media comprising polyamines and a plant- and/or yeast-derived hydrolysate. The invention also relates to animal protein-free culturing processes, wherein cells can be cultivated, propagated and passaged without adding supplementary animal proteins in the culture medium. These processes are useful in cultivating cells, such as recombinant cells or cells infected with a virus, and for producing biological products by cell culture processes.

Claims (6)

1. A method for expressing a Factor VIII protein, comprising the steps of:

a) providing a culture of CHO cells into which a nucleic acid comprising a sequence encoding the Factor VIII protein has been introduced;

b) culturing the cells in an animal protein-free cell culture medium under conditions in which the Factor VIII protein is expressed, wherein the animal protein-free cell culture medium comprises putrescine at a concentration ranging from about 0.5 mg/L to about 10 mg/L and soy hydrolysate in a concentration ranging from about 0.05% (w/v) to about 0.5% (w/v), wherein the level of expression of the Factor VIII protein per cell is increased.

2. The method of claim 1 , wherein the animal protein-free cell culture medium comprises putrescine in a concentration ranging from about 2 mg/L to about 8 mg/L.

3. The method of claim 1 , wherein the animal protein-free cell culture medium comprises putrescine in a concentration ranging from about 2 mg/L to about 5 mg/L.

4. The method of claim 1 , wherein the CHO cells are cultivated by chemostat cultivation.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2021
From: BAXALTA GMBH; BAXALTA INCORPORATED
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 055189/0005 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 21, 2015
From: BAXTER INTERNATIONAL INC.
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 036410/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA PREVIOUSLY RECORDED AT REEL: 036359 FRAME: 0001. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 21, 2015
From: BAXTER HEALTHCARE SA
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 036411/0400 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2015
From: BAXTER HEALTHCARE S.A.
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 036359/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 10, 2010
From: GRILLBERGER, LEOPOLD; REITER, MANFRED; MUNDT, WOLFGANG; DORNER, FRIEDRICH
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE S.A.
Reel/Frame 025471/0684 →